cytarabine has been researched along with deamino arginine vasopressin in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (66.67) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Leone, G; Pagano, L; Sica, S; Voso, MT | 1 |
| Ino, Y; Moriwaki, H; Murakami, N; Muto, Y; Tsurumi, H; Yamada, T | 1 |
1 review(s) available for cytarabine and deamino arginine vasopressin
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
2 other study(ies) available for cytarabine and deamino arginine vasopressin
| Article | Year |
|---|---|
Recovery from diabetes insipidus associated with AML after a BMT conditioning regimen including busulfan.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Purging; Bone Marrow Transplantation; Busulfan; Cytarabine; Daunorubicin; Deamino Arginine Vasopressin; Diabetes Insipidus; Humans; Incidence; Leukemia, Myelomonocytic, Acute; Male; Remission Induction | 1993 |
[Acute myelogenous leukemia with diabetes insipidus without desmopression administration by anti-leukemic chemotherapy].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Daunorubicin; Deamino Arginine Vasopressin; Diabetes Insipidus; Female; Humans; Leukemia, Myeloid, Acute; Mercaptopurine; Prednisolone; Renal Agents | 1995 |